Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Retained Earnings (2019 - 2025)

Cresco Labs' Retained Earnings history spans 7 years, with the latest figure at -$1.5 billion for Q4 2025.

  • For Q4 2025, Retained Earnings fell 67115.23% year-over-year to -$1.5 billion; the TTM value through Dec 2025 reached -$1.5 billion, down 67115.23%, while the annual FY2025 figure was -$1.5 billion, 67115.23% down from the prior year.
  • Retained Earnings reached -$1.5 billion in Q4 2025 per CRLBF's latest filing, down from -$2.2 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$1.4 million in Q4 2022 to a low of -$1.5 billion in Q4 2025.
  • Average Retained Earnings over 5 years is -$722.3 million, with a median of -$841.9 million recorded in 2021.
  • Peak YoY movement for Retained Earnings: surged 99.83% in 2022, then plummeted 90749.68% in 2023.
  • A 5-year view of Retained Earnings shows it stood at -$841.9 million in 2021, then soared by 99.83% to -$1.4 million in 2022, then tumbled by 90749.68% to -$1.3 billion in 2023, then soared by 99.82% to -$2.2 million in 2024, then plummeted by 67115.23% to -$1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Retained Earnings are -$1.5 billion (Q4 2025), -$2.2 million (Q4 2024), and -$1.3 billion (Q4 2023).